Ameriprise
IDYA icon

Ameriprise’s IDEAYA Biosciences IDYA Stock Holding History

Ameriprise’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7M Buy
45,688
+425
+0.9% +$13K ﹤0.01% 3163
2026
Q1 		$1.51M Buy
45,263
+309
+0.7% +$10.4K ﹤0.01% 3098
2025
Q4 		$1.55M Buy
44,954
+74
+0.2% +$2.36K ﹤0.01% 3129
2025
Q3 		$1.22M Buy
44,880
+4,430
+11% +$107K ﹤0.01% 3256
2025
Q2 		$850K Sell
40,450
-228,614
-85% -$4.39M ﹤0.01% 3335
2025
Q1 		$4.41M Sell
269,064
-18,938
-7% -$403K ﹤0.01% 2408
2024
Q4 		$7.4M Buy
288,002
+10,072
+4% +$285K ﹤0.01% 2044
2024
Q3 		$8.8M Buy
277,930
+213,018
+328% +$8.08M ﹤0.01% 1910
2024
Q2 		$2.28M Sell
64,912
-148,602
-70% -$5.88M ﹤0.01% 2805
2024
Q1 		$9.37M Sell
213,514
-10,627
-5% -$457K ﹤0.01% 1842
2023
Q4 		$7.97M Sell
224,141
-49,332
-18% -$1.47M ﹤0.01% 1982
2023
Q3 		$7.38M Buy
273,473
+31,312
+13% +$794K ﹤0.01% 1952
2023
Q2 		$5.69M Sell
242,161
-191,521
-44% -$3.94M ﹤0.01% 2244
2023
Q1 		$5.95M Buy
433,682
+23,112
+6% +$385K ﹤0.01% 2196
2022
Q4 		$7.46M Buy
410,570
+348,005
+556% +$5.85M ﹤0.01% 1999
2022
Q3 		$933K Sell
62,565
-1,913
-3% -$24.8K ﹤0.01% 3142
2022
Q2 		$889K Buy
64,478
+2,937
+5% +$32.7K ﹤0.01% 3166
2022
Q1 		$688K Sell
61,541
-2,100
-3% -$31K ﹤0.01% 3361
2021
Q4 		$1.5M Buy
63,641
+48,421
+318% +$1.12M ﹤0.01% 3068
2021
Q3 		$388K Hold
15,220
– – ﹤0.01% 3485
2021
Q2 		$319K Hold
15,220
– – ﹤0.01% 3617
2021
Q1 		$358K Hold
15,220
– – ﹤0.01% 3530
2020
Q4 		$213K Buy
15,220
+110
+0.7% +$1.49K ﹤0.01% 3607
2020
Q3 		$190K Buy
+15,110
New +$187K ﹤0.01% 3553

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Ameriprise's IDYA Position: Q2 2026 in Review

Ameriprise increased its IDEAYA Biosciences (IDYA) stake by 0.94% in Q2 2026, buying an estimated $13K and bringing the position to 45,688 shares worth $1.7M. The position accounts for ﹤0.01% of the portfolio, ranked #3163.

Ameriprise first reported a position in IDYA in Q3 2020 and has held it in 24 quarters since. The position peaked at $9.37M in Q1 2024. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Ameriprise held 45,688 shares of IDEAYA Biosciences worth $1.7M as of Q2 2026.
  • Ameriprise bought 425 IDEAYA Biosciences shares in Q2 2026, an estimated $13K.
  • IDEAYA Biosciences made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3163 holding.
  • Ameriprise first reported a position in IDEAYA Biosciences in Q3 2020 and has held it in 24 quarters since.
  • Ameriprise's IDEAYA Biosciences position peaked at $9.37M in Q1 2024.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.